Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.
The average age of men who get diagnosed is 67.
About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results